INTRODUCTION
============

Bone morphogenetic proteins (BMPs) are members of the transforming growth factor β (TGF-β) superfamily ([@B28]; [@B110]; [@B78]). BMPs were originally identified as factors that induce bone formation when implanted at ectopic sites ([@B119]). Later, it was shown that BMP functions exist in vertebrates as well as in invertebrates and that they perform a wide range of biological action in various cell types and tissues ([@B20]). BMPs control many indispensable steps in embryogenesis, including the formation and differentiation of the vertebrate nervous system ([@B73]; [@B54]; [@B63]). At initial steps of development, BMP inhibition is required to establish neuroectoderm from ectoderm, although certain levels of BMP signaling are later required for neural crest induction, neural crest cell migration, and spinal cord patterning. At later development stages, BMP signaling promotes astrogliogenesis and inhibition of neuronal or oligodendroglial lineage commitment. Given the functions of BMPs in nervous system development and maintenance, BMP signaling dysfunction and modulation could have a strong impact on various nervous system pathologies as well as their repair processes ([@B70]; [@B99]; [@B66]). In this review, we highlight the main aspects of BMP signaling and BMP's involvement in neural induction and patterning, embryonic and postnatal neuronal differentiation, and the establishment of neuronal connections.

SIGNALING BY BMPs
=================

Bone morphogenetic proteins are the largest subfamily of the TGF-β superfamily, which includes 33 members in mammals. BMPs can be further classified into at least four subgroups: BMP-2/4 group, BMP-5/6/7/8 group, growth and differentiation factor-5,-6,-7 (GDF-5/6/7) group, and BMP-9/10 group ([@B62]; [@B78]; [@B122]). BMPs are known to be involved in many developmental and homeostatic processes throughout life. However, the exact function of individual BMPs in a particular tissue and at a specific time during development is far from clear. Due to their pleiotropic roles, genetic manipulation often leads to embryonic lethality, thus precluding analysis of their later embryonic or postnatal functions in multiple tissues and organs ([@B15]). In addition, compensatory functional overlaps between BMPs make interpretation complicated. Furthermore, although we may have a rough estimate of the place and the timing of expression of a particular BMP, many factors present in the extracellular environment are able to modify its exact diffusion rate, morphogen range, and its bioavailability for a target cell ([@B33]; [@B84]).

BMP SECRETION AND EXTRACELLULAR REGULATION
------------------------------------------

Bone morphogenetic proteins are synthesized as large precursor proteins comprising an N-terminal signal peptide, which directs the protein to the secretory pathway, a prodomain for proper folding and a C-terminal mature peptide ([@B111]). BMPs are first secreted and then proteolitically cleaved upon dimerization by serine proteases such as furin or PC6, releasing the mature peptide ([@B27]). Active BMPs consist of two monomers stabilized by three intramolecular disulfide bonds, known as cysteine knots, and an inter-dimer disulfide bond ([@B105]). Mature forms may be either homo- or hetero-dimers consisting of different BMP gene products. It has been shown *in vivo* and *in vitro* that some hetero-dimerization could lead to increased functional activity ([@B120]). In some cases, the cleaved prodomain remains attached to the mature form, as in the case of TGF-β, leading to reduced bioavailability and retention in the extracellular matrix ([@B90]).

This restricted availability to their membrane receptors is mostly emphasized by the existence of highly regulated diffusible and cell surface-bound antagonists. There are more than a dozen diffusible antagonists that include chordin, noggin, follistatin, and chordin-like proteins ([@B92]; [@B123]; [@B137]). Binding of antagonists physically prevents BMPs from binding to their cognate receptors by masking the epitopes involved in ligand--receptor interactions ([@B45]; **Figure [1](#F1){ref-type="fig"}**). Subsequent cleavage of chordin by tolloid zinc metalloproteinases triggers the release of active BMPs from the chordin/BMP complex ([@B84]). Twisted gastrulation (Tsg) has a dual role in distinct model systems, acting as either a BMP antagonist or as an agonist. In the case of chordin, the stability of the chordin/BMP complex is greatly increased by *Tsg* ([@B19]; [@B93]).

![**Canonical BMP signaling**. BMPs bind to the BMP receptors type I and II, and then type II receptor phosphorylates and activates the type I BMP receptor. Activated type I receptor phosphorylates R-Smads, which associate with the common Smad (Smad4) and enter the nucleus, where they regulate transcriptional processes. BMP signaling can be inhibited by extracellular antagonists, such as Noggin and Chordin, or intracellularly by I-Smads.](fncel-07-00087-g001){#F1}

Finally, regulation of BMP transport is crucial for its role as a morphogen. It has been shown that BMP-2 has the ability to link directly to heparan sulfate proteoglycans (HSPGs). In several experimental models, extracellular HSPGs and collagen IV have been involved in the regulation of BMP transport ([@B95]; [@B83]). Collagen IV binds to BMP-4 and chordin homologs, sequestering them in the extracellular matrix. As mentioned above, Tsg, acting as a BMP agonist, releases chordin/BMP complexes from the collagen IV matrix, allowing their diffusion ([@B104]). Thus, all these events of binding of BMPs to the extracellular matrix and/or to antagonists allow the formation of specific gradients through regulated solubility and bioavailability and constitute the first level of signal modulation.

BMP RECEPTORS AND RECEPTOR ACTIVATION
-------------------------------------

Bone morphogenetic proteins bind to a heterotetrameric complex of transmembrane receptors known as type I and II serine/threonine kinase receptors ([@B79]). Both types of receptors contain an N-terminal extracellular binding domain, a single transmembrane region, and an intracellular serine/threonine kinase domain ([@B110]; [@B35]; [@B78]). Strong evidence confirms that both type I and II receptors, acting in coordination, are required for complete signal transduction. BMPs can bind to type I in the absence of type II receptors but when both types are present in the membrane of target cells their binding affinity is highly increased ([@B50]; **Figure [2](#F2){ref-type="fig"}**). Based on their structures and functions, type I BMP receptors can be divided into the Bmpr1A and Bmpr1B group (also known as Alk3 and Alk6) and the Acvrl1 and Acvr1 group (also known as Alk1 and Alk2; [@B50]). These groups show slight preferences for binding to specific BMPs. For instance, BMP-2 and -4 bind preferentially Bmpr1A and Bmpr1B whereas BMP-5, -6, and -7 additionally bind to Acvr1 ([@B64]). It is also well established that BMPs bind to three distinct type II receptors, namely Bmpr2, Acvr2A, and Acvr2B (**Figure [2](#F2){ref-type="fig"}**). Bmpr2 shows a unique, long C-terminal extension that allows specific recruitment of intracellular transducers. A question arises as to how such a limited number of signaling receptors allows binding of a large number of ligand members. One simple answer would rely on promiscuous interactions between shared ligands and several receptors ([@B50]; [@B79]). However, combinatorial interactions of different type I and II receptors should allow selectivity and specificity of ligand binding as well as intracellular signaling in target cells. Numerous *in vivo* examples confirm the unique functions for an individual BMPs that are not shared even for closely related ligands with similar receptor binding affinities *in vitro* ([@B103]; [@B75]; [@B85], [@B86]). Further study into the molecular mechanisms that drive such functional specificity in living organisms is needed.

![**Non-canonical BMP signaling**. In addition to Smads, activated BMP receptors activate several intracellular pathways which modulate BMP-dependent cellular responses. Pathways include TAK-p38, PI3-kinase, Cdc42 or activation of LIMK by binding to the BMPR-II cytoplasmic tail.](fncel-07-00087-g002){#F2}

Moreover, co-receptors have been shown to modulate ligand binding and downstream signaling events. Members of the repulsive guidance molecule (RGM) family are glycophosphatidylinositol (GPI)-anchored co-receptors for BMP-2 and -4 and enhance responses at low BMP concentrations ([@B131]). Dragon and hemojuvelin (RGMb and c, respectively) also interact with BMP receptors and ligands and enhance responses for BMP-2 and -6. It has been shown that hemojuvelin plays a major role in regulation of iron metabolism in hepatocytes by increasing the binding affinity of BMP receptors for BMP-6 ([@B4]). In addition to facilitating co-receptors, other membrane proteins function as suppressors of BMP signaling. For instance, Bambi is a transmembrane protein, structurally related to type I receptors that act as pseudoreceptor. Bambi forms a stable receptor complex but, since it lacks the intracellular kinase domain, inhibits transduction by titrating available type II receptors ([@B82]).

Type I and II BMP receptors show some ligand-independent affinity for each other. In the absence of a ligand, small amounts of pre-existing homo- and hetero-dimer receptor complexes are present at the cell surface ([@B32]). However, ligand binding dramatically increases oligomerization involving type I and II complexes. Ligand-induced oligomerization promotes type II-dependent phosphorylation of a specific domain of type I receptors (known as the GS domain; **Figure [1](#F1){ref-type="fig"}**). Upon phosphorylation of the GS domain the type I receptor kinase is converted to its active conformation ([@B129]). Thus, the kinase activity of type I receptors is the major intracellular transducer: whereas mutated or kinase-deficient type I receptors block most of the cellular responses to the ligand, constitutively active type I receptors (induced by pathological mutations or artificially designed) are able to signal most of the responses in the absence of type II receptors or ligands ([@B127]).

INTRACELLULAR Smad SIGNALING FROM BMP RECEPTORS
-----------------------------------------------

Smads are the main and best-known intracellular signal transducers for BMP receptors. According to their structural and functional properties, three different types of Smads have been defined: the receptor-regulated Smads (R-Smad) Smad1, -2,-3,-5, and -8; a common mediator Smad, Smad4; and the inhibitory Smads Smad6 and -7 ([@B110]; [@B111]; [@B78]). Active type I kinases phosphorylate R-Smads at serine residues located in their C-terminus. Specific phosphorylation of different R-Smads depends on the L45 loop of the type I receptor ([@B34]). All the BMP type I receptors mentioned above (BMPR1A, BMPR1B, Acvr1, and Acvrl1) phosphorylate Smad1, Smad5, and Smad8, which are thus defined as BMP-activated Smads. Phosphorylation and activation of R-Smads disrupts the autoinhibitory interaction between the N-terminal (MAD homology 1, MH1) and C-terminal (MH2) domains of Smad monomers ([@B109]). This favors the formation of a multimeric complex composed of two molecules of R-Smad and one molecule of Smad4 interacting through their MH2 domain (**Figure [1](#F1){ref-type="fig"}**). On the new conformation, the nuclear import signal is exposed and the complexes translocate into the nucleus where they execute distinct transcriptional regulatory functions ([@B35]; [@B49]).

Intracellular BMP signaling, as shown for transduction of all other morphogens described so far, is subjected to a growing number of cross-talk mechanisms with other extracellular ones, as well as regulation by internal cues, in order to integrate a final cell response. For instance, the inhibitory Smads, Smad6, and Smad7, block BMP signaling by preventing phosphorylation of R-Smads by type I receptors in a dominant negative fashion by binding to active receptor complexes ([@B28]). Another known mechanism is the degradation of Smads through the ubiquitin--proteasome pathway. Several homologous to E6-associated protein C-terminus (HECT)-type E3 ligases, such as Smurf-1,-2, or Nedd4-2, interact and ubiquitinate Smads and, when complexed with I-Smads, BMP receptors ([@B126]). Degradation of Smads is also regulated by mitogen-activated protein (MAP) kinase and Gsk-3 phosphorylation allowing specific interaction with MAP kinase and Wnt signaling cascades ([@B39]).

NON-CANONICAL SIGNALING FROM BMP RECEPTORS
------------------------------------------

In addition to Smads, BMPs activate other intracellular signaling pathways relevant to their cell functions. Non-canonical BMP signaling includes Rho-like small GTPases, phosphatidylinositol 3-kinase/Akt (PI3K/Akt) or various types of MAP kinases ([@B28]; [@B138]; **Figure [2](#F2){ref-type="fig"}**). Mechanistically, it is well established that BMPs regulate the Tak1/p38 pathway through recruitment and ubiquitylation of Traf6 by activated receptor complexes ([@B114]; [@B133]). BMPs trigger canonical and non-canonical pathways simultaneously, driving to a specific cellular output ([@B118]; [@B132]; [@B116]). Several studies indicate that BMP-mediated cell migration or axon and dendrite growth requires activation of the small GTPase Cdc42 and Limk activities. Most of these effects are Smad-independent, but depend on Limk binding to the long cytoplasmatic tail of Bmpr2 complexes ([@B38]; [@B57]). Furthermore, additional reports indicate that activation of Limk also requires the activation of Paks through Cdc42 and PI3K, as well as p38 MAP kinase activities ([@B43], [@B44]). The specific abilities of distinct receptors or receptor combinations to activate these non-canonical pathways and promote specific signaling outcomes need to be studied.

BMPs IN NERVOUS SYSTEM DEVELOPMENT AND MAINTENANCE
==================================================

In recent years, there has been exponential progress in the clarification of the role of BMPs at different stages of nervous system development. BMP ligands and receptors are expressed in very complex patterns throughout neural development in all regions of the central and peripheral nervous system ([@B31]; [@B77]). Evidence clearly demonstrates that these pleiotropic cytokines have a very dynamic role: from the early steps of neuralization and patterning to an instructive role in neural precursor fate commitment and neuronal wiring ([@B63]). Evidence also extends their role in postnatal brain as well as peripheral nervous system development and maintenance ([@B14]; **Figure [3](#F3){ref-type="fig"}**).

![**Roles of BMP signaling in neural development**. Initially, inhibition of BMP signaling is required for neuroectoderm induction. BMPs generate a signaling gradient and promote dorsomedial identity. BMP signaling is prominent at the dorsal telencephalic midline and in the marginal zone neurons, where it correlates negatively with expression of the cortical selector *Lhx2*, *Fgf8*, or *Shh.* In late embryogenesis and postnatally, BMP signaling promotes astroglial commitment by activation astrocyte-specific promoters through a Stat3-p300/CBP-Smad1 complex. At the same time represses commitment to the other two neural lineages by inducing Ids and Hes proteins. In adulthood, a balanced BMP signaling is required for regulation of quiescence and differentiation of neural stem cell populations in the SVZ and SGZ.](fncel-07-00087-g003){#F3}

EXPRESSION AND ROLE OF BMPs AND RECEPTORS IN TELENCEPHALIC TISSUES
------------------------------------------------------------------

Bone morphogenetic proteins and their antagonists are expressed throughout neural development with a complex chronological and overlapping location that is only known to a limited extent. In early-developing neural tissue, BMPs are expressed particularly at the lateral edges of the neural plate and later on in the dorsal midline of the neural tube ([@B73]; [@B21]). During vertebrate development, the rostral--dorsal part of the neural plate gives rise to the telencephalon, the most complex region of the nervous system. The two signaling centers in the dorsal midline of the telencephalon, the roof plate and the cortical hem, secrete several BMPs ([@B42]). These BMPs generate a signaling gradient and promote dorsomedial identity. Mice that are transgenic for specific BMP-dependent reporters indicate that, at embryonic stages, high BMP signaling is prominent at the dorsal telencephalic midline and in the marginal zone neurons, where it correlates negatively with expression of the cortical selector *Lhx2* ([@B29]). BMPs also reduce the expression of the anterior forebrain markers *Fgf8* or *Shh* ([@B2]; **Figure [3](#F3){ref-type="fig"}**). *Chordin* and *noggin* double mutant embryos further emphasize the importance of the appeasement of BMP signaling for proper ventral forebrain development ([@B2]). During further embryo development, brain expression of BMP-2, -4, -5, -6, and -7 peaks around postnatal day 4 with a broad expression pattern ([@B73]; [@B99]). Particular areas of the telencephalon, such as the hippocampus or cerebral cortex, show strong postnatal BMP activation ([@B29]). In adult telencephalon, there is also broad expression of BMPs at most locations and cell types, suggesting also a pivotal role in the adult brain. Interestingly, expression of BMPs and their antagonists specifically remain in the two areas where neurogenesis continues in the adult \[the subventricular zone (SVZ) and subgranular zones (SGZ); [@B14]\]. Expression of BMPs, from stem cells and neural progenitors, and noggin, secreted from ependymal cells, is essential for stem cell niche maintenance and neuroblast survival ([@B61]; [@B76]; **Figure [3](#F3){ref-type="fig"}**). Moreover, increased expression of BMPs occurs after distinct brain and spinal cord injuries and suggest a role of BMP signaling in neural cell survival and repair ([@B99]).

Bone morphogenetic protein receptors are expressed at high levels throughout all stages of embryonic development but show different expression patterns. *Bmpr1A* is expressed earlier than *Bmpr1B*. *Bmpr2* is mostly restricted to proliferative regions of the nervous system, whereas *Acvr2* and *Acvr1* have also been detected in early neural development and are expressed at high levels in adult brain. Bmpr1A and Bmpr1B are required separately in some development processes although in several studies of neural development, each receptor could, at least partially, compensate for the loss of the other. For instance, deletion of *Bmpr1B* causes no obvious forebrain phenotype ([@B136]). However, the requirement of BMP signaling for dorsal telencephalic development is shown after forebrain-specific ablation of *Bmpr1A* or the double knock-out of *Bmpr1A* and *Bmpr1B*, which leads to holoprosencephaly ([@B37]). However, later ablation only affects formation of the dentate gyrus of the hippocampus ([@B17]). In adult telencephalon, expression of all these receptors remains, with *Bmpr1A* the most abundant and broadly expressed one ([@B77]). All cell types (neurons, astroglia, oligodendroglia, or ependymal cells) express combinations of these receptors ([@B18]; [@B14]). Interestingly, some reports suggest that their expression pattern is differentially distributed within a single neuron, with Bmpr1A mainly expressed in cell bodies and Bmpr1B in dendrites ([@B77]).

BMPs IN EMBRYONIC AND ADULT NEURAL CELL SPECIFICATION
-----------------------------------------------------

The central and peripheral nervous systems originate from neural progenitor cells, which proliferate and give rise to the three main neural cell types: neurons, astrocytes, and oligodendrocytes. The specification and differentiation of the distinct cell types require interactions between cell-autonomous molecular mechanisms and external signaling cues ([@B73]; [@B72]; [@B63]). Remarkably, BMPs are critical for progenitor cell specification and maintenance of a particular phenotype through dynamic transcriptional regulation ([@B14]). BMPs decrease proliferation of neural progenitors in cell culture models as well as *in vivo* in combination with other signaling molecules and internal cues ([@B23]; [@B115]; [@B8]).

### BMP role in neurogenesis

Neurogenesis is promoted by proneuronal basic helix-loop-helix (bHLH) transcription factors including Mash1, Neurogenin, or NeuroD, which form hetero-dimers with ubiquitously expressed bHLH E proteins, such as the E2A gene products, E12 and E47, through their HLH domain ([@B94]; [@B51]). Hetero-dimers bind to DNA through their basic domain and activate the transcription of genes that have E boxes in their promoter region (**Figure [4A](#F4){ref-type="fig"}**). One subfamily of HLH factors, known as Id proteins, lacks this basic region. Hetero-dimerization of Id with bHLH is sufficient to block their DNA binding and function ([@B81]; [@B96]). Moreover, Ids not only inhibit transcriptional function but also promote the degradation of neurogenic bHLH by sequestering ubiquitous E proteins ([@B121]; **Figure [4B](#F4){ref-type="fig"}**). Similarly, the Hes family of bHLH transcriptional repressors blocks neuronal differentiation through a dominant negative function on E protein availability as well as through direct binding on specific promoters and recruitment of members of the Grouch family of transcriptional repressors (**Figure [4B](#F4){ref-type="fig"}**). BMPs have been shown to be strong inducers of both *Id* and *Hes* family members ([@B94]). Thus, Id and Hes family members are thought to be major molecular players in the negative effects of BMPs on commitment and differentiation of neuronal precursors ([@B117]; [@B52]). Furthermore, BMPs have been proved to increase the expression of the transcriptional repressor *Rest/Nsrf*. Expression of *Rest/Nsrf* allows continuous repression of the neuronal markers in cells committed to other lineages ([@B55]). In addition to their effects on embryonic neurogenesis, BMPs are widely accepted as relevant molecules in adult neurogenesis. In adult telencephalon, neural stem cell populations are maintained in two niches: the SVZ and the SGZ of the dentate gyrus. [@B25] showed, through conditional deletion of *Smad4* or noggin infusion, that BMP signaling was required for adult neurogenesis. Noggin can also expand hippocampal progenitors in the SGZ ([@B13]). Infusion of Noggin and genetic deletion of either *Bmpr1A* or *Smad4* further demonstrate the role of BMP signaling in regulation of quiescence of neural stem cells from SGZ, restraining their proliferation and allowing these niches to maintain long-term neurogenic ability ([@B76]). BMP signaling is also required for positional identity and neuronal subtype specification. Endogenously produced BMPs inhibit the expression of a telencephalic gene profile, which was revealed by addition of noggin or other pharmacological signaling inhibitors ([@B9]). BMPs are also involved in regulation of a transcriptional network to generate forebrain cholinergic neurons ([@B11]). They also determine a temporally and spatially restricted requirement for generation of glutamatergic neurons in cerebellum ([@B36]).

![**Model of mechanism of repression of neurogenic bHLH transcription factors by BMPs**. **(A)** In differentiating neurogenic precursors, bHLH transcription factors hetero-dimerizes with E proteins, which bind to E boxes and promote expression of neuronal genes. **(B)** Activation of the BMP signaling pathway leads to increased levels of Id and Hes proteins. Id and Hes proteins sequester E proteins away from bHLH transcription factors, which leads to transcriptionally inactive complexes and also enhance degradation of bHLH monomers. Furthermore Hes proteins can bind to N boxes sequences in neural promoters and recruit the Groucho family of transcriptional repressors.](fncel-07-00087-g004){#F4}

### BMP role in oligodendrogenesis

Oligodendrocyte specification and maturation depend on the function of transcription factors that include Olig1, Olig2, and Sox10. Olig2 directs early oligodendrocyte specification and Olig1 promotes oligodendrocyte maturation and is required for repair of demyelinated lesions ([@B65]; [@B60]; [@B59]). BMPs inhibit the development of several stages of oligodendrocyte differentiation as well as the timing of myelination as shown by expression analysis markers of oligodendrocyte differentiation such as A2B5, galactocerebroside, or myelin protein expression ([@B47]; [@B100]; [@B21]; [@B108]; [@B125]). Conversely, noggin blocks production of astrocytes from oligodendrocyte precursors in culture ([@B112]). BMP-4 stimulation increases oligodendrocyte progenitor proliferation in a model of induced demyelination. More importantly, addition of noggin increases the number of mature oligodendrocytes and increased the remyelination of injured axons in the corpus callosum ([@B97]; [@B130]; [@B98]). At the molecular level, BMP-induced expression of Id and Hes proteins seems to be also relevant in such a process by sequestering Olig1 and Olig2 which also belong to the bHLH family of transcription factors ([@B22]; [@B10]). Additional targets of Notch, such as *Jag1*, *Hey1*, and *Hey2*, are upregulated by BMP in oligodendrocytes through increased epigenetic modification at these loci ([@B130]). Inhibition of *Olig2* expression by direct binding of Smad4 to the *Olig2* promoter has also been demonstrated ([@B10]; **Figure [3](#F3){ref-type="fig"}**). Recently, it has also been shown that the Smad-interacting protein-1 (Sip1) is an essential *in vivo* modulator of myelination. Sip1 antagonizes BMP signaling acting as a transcriptional repressor of Smad activity, while promoting activation of Olig1/Olig2 transcriptional activity and induction of I-Smads ([@B125]).

### BMP role in astrocytogenesis

In opposition to the repression of neuronal and oligodendrocyte development, during the late embryonic and postnatal periods, BMP signaling strongly induces astrocyte differentiation ([@B46]; [@B73]; [@B41]; [@B107]). BMPs promote the generation of astrocytes from precursors in a variety of embryonic neural cells ([@B46]; [@B73]; [@B72]; [@B12]). Implantation of noggin-producing cells induced the appearance of increased numbers of oligodendrocyte precursors whereas high BMP signaling inhibits oligodendrocyte precursors and promote astrogliogenesis ([@B67]; [@B74]; [@B130]). BMP signaling in the SVZ promotes astroglial lineage commitment and block differentiation of neurons and oligodendrocytes, whereas noggin suppresses astrocyte determination ([@B23]; [@B25]). LIF and BMPs synergize to promote astrocytic differentiation by activating astrocyte-specific promoters through a Stat3-p300/CBP-Smad1 complex ([@B80]; **Figure [3](#F3){ref-type="fig"}**). The ability of BMPs and Stat3 to promote astrogliogenesis has been shown to be dependent on the histone acetylation/deacetylation machinery ([@B106]). Another study indicated that Smad action is not required for gliogenesis but is promoted by BMPs through mammalian target of rapamycin/FKBP12-rapamycin-associated protein (mTor/Frap) phosphorylation of Stats ([@B89]). Interestingly, Bmpr1A or Bmpr1B signaling exerts opposing effects on initial astrocytic hypertrophy after injury, suggesting that distinct BMPs engaging different receptor complexes exert separate activities on gliogenesis. The ability of BMPs to promote maturation of astroglia is further emphasized by the fact that activation of BMP signaling inhibits the tumorigenic potential of human glioblastoma-initiating cells ([@B87]). Furthermore, Ezh2-dependent epigenetic silencing of *Bmpr1B* desensitizes tumor-initiating glioblastoma cells to differentiation and contributes to their tumorigenicity ([@B56]).

BMP SIGNALING IN NEURITE AND AXON OUTGROWTH, GUIDANCE AND SYNAPSE FORMATION
---------------------------------------------------------------------------

After neurogenesis has been completed, several sequential events are needed to establish neuronal circuits: polarized outgrowth of axons and dendrites, axon path finding toward the appropriate synaptic partner cell and establishment and maintenance of the synapse. Growing evidence in several experimental models points to BMP regulation of all these events. For instance, BMP ligands display positive regulation of the number, length, and branching of neurites in neurons from diverse neuronal origins, including cortical and hippocampal neurons ([@B58]; [@B128]; [@B57]; [@B88]). Similarly, BMPs have been included as inductive signals promoting growth cone guidance as well as axonal orientation and path finding. Most of the data arise from studies of the sensory projection neurons of the spinal cord. BMP-7 and GDF-7 supplied by the roof plate orient axons of commissural neurons away from the roof plate and regulate their rate of extension through the spinal cord toward the floor plate ([@B3]; [@B16]; [@B134], [@B135]; [@B101]). Guideposts are discrete groups of glial or neuronal cells that provide discontinuous information in intermediate positions along the path of growing axons ([@B101]). The corpus callosum represents the major forebrain commissure connecting the two cerebral hemispheres. Midline crossing of callosal axons is controlled by several glial and neuronal guideposts specifically located along the callosal path. BMP-7 has been shown to be required at different steps of organization and differentiation of these guidepost cells, which allows formation of the corpus callosum ([@B102]). Additional evidence also indicates that BMP-7, secreted from the meninges, is involved in a morphogenic cascade, including Wnt3a and GDF-5, allowing correct corpus callosum development and prevents premature axon projection ([@B24]). It is not clear which signaling mechanisms are activated by BMP in these processes. In contrast to the slow timing of neural and glial specification, the very rapid time course of BMP-induced axonal orientation suggests transcription-independent pathways, probably depending on cytoskeletal actin remodeling and c-Jun N-terminal kinase (Jnk)-mediated microtubule stabilization ([@B3]; [@B124]; [@B88]; [@B85]). Regulation of the cytoskeleton by BMPs has been linked to activation of Limk1 activation. Limk1 and Limk2 are closely related kinases that phosphorylate and inactivate actin-depolymerizing proteins such as cofilin or ADF. Limk1 has been shown to be activated by several BMPs in neural cells through specific binding to the Bmpr2 cytoplasmic tail and a further activation mechanism that involves Rho GTPases and PI3-kinase ([@B38]; [@B57]; [@B30]; [@B43]). Limk phosphorylation of cofilin/ADF is counteracted by the action of the Slingshot phosphatase, which is activated at later times after BMP addition and enables chemotactic responses to change from attraction to repulsion ([@B124]).

An intriguing functional and mechanistic question is that, whereas the closely related BMP-6 and -7 both induce the differentiation of commissural neurons, only BMP-7 is able to orients its axons *in vitro* and is required for appropriate axon projection *in vivo* ([@B85], [@B86]). Both ligands have been reported to bind hetero-dimers consisting of Acvr2A or Bmpr2 with Acvr1, Bmpr1A or Bmpr1B in numerous cellular models ([@B79]). However, the facts that a single amino acid swapping allows BMP-6 to orient axons and *vice versa* and that binding of BMP-6 to type I receptor depends on N-glycosylation, suggest that distinct receptor recruitment is involved in these functional differences ([@B103]; [@B86]). Changes in expression of BMP receptor subunits at growth cones have been shown after motor neuronal differentiation ([@B7]). Moreover, whereas neuronal specification is a redundant function of Bmpr1A and Bmpr1B, axon outgrowth and regulation of cofilin activity only depend on *Bmpr1B* ([@B134], [@B135]).

### BMP role in synaptogenesis

Once axons reach their corresponding target, two-way communication between presynaptic and postsynaptic cells is needed for synaptic establishment and homeostasis during development and for proper synaptic plasticity. The *Drosophila* larval neuromuscular junction (NMJ) is a useful model for genetic and biochemical studies of synaptic function ([@B26]). Development of the synapse requires an anterograde as well as retrograde input from the synaptic terminal and target cell. BMP signaling is an indispensable component of retrograde signaling in the NMJ ([@B48]). The muscle-secreted BMP ligand *glass bottom boat* (*Gbb*), signals through presynaptic *wishful thinking* (*Wit*), the Bmpr2 homolog, and the receptor type I homologs *thick veins* and *saxophone* (*Tkv* and *Sax*, respectively; [@B1]; [@B68], [@B69]; [@B91]). *Wit* mutant larvae show complete presynaptic detachment, which could be rescued by its expression in presynaptic cells ([@B1]; [@B68]). Similarly, *Gbb* expression in muscle, but not in neurons, rescues NMJ defects observed in *Gbb* mutants ([@B69]). Retrograde *Gbb* activation of synaptic receptors has two parallel effects. One is activation of Limk1 that allows stabilization of the synapse. In the absence of *Limk1*, synaptic footprints are observed in the NMJ. In these footprints the presynaptic components are missing ([@B30]). Since presynaptic development precedes postsynaptic development, synaptic footprints have been interpreted as being the remnants of mature synaptic contacts that have formed and then retracted. The other effect involves activation of the Smad homologs *Mad* and *Medea* and their transport to the neuronal soma to regulate transcription at the nucleus (**Figure [5](#F5){ref-type="fig"}**). There, Mad-dependent transcription of the Rac-guanine nucleotide exchange factor (GEF) *Trio* is relevant for proper NMJ growth and branching since transgenic expression of *Trio* partially rescues BMP signaling mutant larvae ([@B5]). Therefore, canonical and non-canonical pathways are involved in coordination of the synaptic growth and stability of NMJ. Interestingly, genes related to several motor diseases such as hereditary spastic paraplegia or amyotrophic lateral sclerosis, have been shown to regulate BMP retrograde signaling in model systems ([@B6]; [@B48]).

![**Retrograde signaling of BMPs in synapse formation**. BMP retrograde transport of endocytosed BMP receptors by dynein motors. Effective retrograde BMP signal also involves specific translation of Smad protein in the axons.](fncel-07-00087-g005){#F5}

An important aspect in BMP retrograde communication is how signals at the synaptic terminal are conveyed to the nucleus to regulate transcription. It has been shown that BMP retrograde signaling along the axon requires dynein retrograde motors ([@B71]). Recently, retrograde transport of endocytosed BMP receptors has been demonstrated, which suggests two populations of phosphorylated Smad transducers, one at the synaptic terminal and one at the cell body ([@B113]; **Figure [5](#F5){ref-type="fig"}**). However, studies of the murine trigeminal sensory system indicate that an effective retrograde BMP signal also involves specific translation of Smad protein in the axon, which is transported to the cell body by dynein motors ([@B53]). Axonal translation of Smads is activated by brain-derived neurotrophic factor (BDNF), thus coupling both morphogens in the homeostasis of synapses. Some questions remain about the exact place of Smad activation and the role of the additional Smads translated in the axon when it is commonly accepted that the intracellular pool of unphosphorylated Smads is relatively high. Another relevant aspect is the role of glial cells in the regulation of synaptogenesis. Glia, associate intimately with synaptic terminals and are required for synaptogenesis. Recent work on NMJ points to a new member of the BMP ligand family, *Maverick* (*Mav*), in controlling synthesis and release of *Gbb*. Mav is released in glial cells surrounding the synapse and reinforces BMP retrograde signaling by transcriptional regulation of the synthesis of *Gbb* in postsynaptic cells ([@B40]). Altogether, evidence points to a very relevant role of BMP ligands in the coordination of several cell types and signaling mechanisms during synaptogenesis.
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